https://doi.org/10.1186/s40425-019-0527-y
K
Katia Cannita
Nini Hospital(LB)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
301
Papers
3.0K
Citations
27
h-index
66
i10-index
Katia Cannita is an academic researcher from Nini Hospital. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Diabetes Treatment and Management & Colorectal Cancer Treatments and Studies. The author has an h-index of 27, co-authored 256 publications.
ORCID: 0000-0002-9409-1171Papers by this author
worksA multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
2019 · Journal for ImmunoTherapy of Cancer · 400 citations
Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity
2003 · British Journal of Cancer · 71 citations
https://doi.org/10.1038/sj.bjc.6600967
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer
2018 · The Breast · 56 citations
https://doi.org/10.1016/j.breast.2018.07.004
Ado-Trastuzumab Emtansine (T-DM1) in HER2+ Advanced Breast Cancer Patients: does Pretreatment with Pertuzumab Matter?
2017 · Future Oncology · 27 citations
https://doi.org/10.2217/fon-2017-0336
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience
2018 · Journal of Cellular Physiology · 26 citations
https://doi.org/10.1002/jcp.27832
Worse prognosis of KRASc.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx)
2013 · BMC Medicine · 23 citations
https://doi.org/10.1186/1741-7015-11-59
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat